Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study

BACKGROUND: World Health Organization has called for research into predictive factors for selecting persons who could be successfully treated with shorter durations of direct-acting antiviral (DAA) therapy for hepatitis C. We evaluated early virological response as a means of shortening treatment an...

Descripción completa

Detalles Bibliográficos
Autores principales: Flower, Barnaby, Hung, Le Manh, Mccabe, Leanne, Ansari, M Azim, Le Ngoc, Chau, Vo Thi, Thu, Vu Thi Kim, Hang, Nguyen Thi Ngoc, Phuong, Phuong, Le Thanh, Quang, Vo Minh, Dang Trong, Thuan, Le Thi, Thao, Nguyen Bao, Tran, Kingsley, Cherry, Smith, David, Hoglund, Richard M, Tarning, Joel, Kestelyn, Evelyne, Pett, Sarah L, van Doorn, Rogier, Van Nuil, Jennifer Ilo, Turner, Hugo, Thwaites, Guy E, Barnes, Eleanor, Rahman, Motiur, Walker, Ann Sarah, Day, Jeremy N, Chau, Nguyen VV, Cooke, Graham S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870305/
https://www.ncbi.nlm.nih.gov/pubmed/36622106
http://dx.doi.org/10.7554/eLife.81801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870305/
https://www.ncbi.nlm.nih.gov/pubmed/36622106
http://dx.doi.org/10.7554/eLife.81801

Ejemplares similares